Search clinical trials for: 68Ga-NOTA-AE105

Total 1710 results

Rigshospitalet, Denmark

Completed

Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer

Head and Neck Cancer

Denmark
Rigshospitalet, Denmark

Recruiting

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Non-small Cell Lung Cancer | Malignant Pleural Mesothelioma | Large Cell Neuroendocrine Carcinoma of the Lung

Denmark
Rigshospitalet, Denmark

Unknown

uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness

Prostate Cancer

Denmark
Rigshospitalet, Denmark
Curasight ApS

Completed

uPAR PET/CT for Preoperative Staging of Breast Cancer Patients

Breast Cancer

Denmark
Rigshospitalet, Denmark

Unknown

uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer

Neoplasms | Neoplasms by Site | Head and Neck Neoplasms | Oral Cancer | Oropharyngeal Cancer | Cancer of Mouth

Denmark
Rigshospitalet, Denmark

Completed

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Neuroendocrine Tumors

Denmark
Rigshospitalet, Denmark

Unknown

uPAR-PET/MRI in Glioblastoma Multiforme

Glioblastoma Multiforme

Denmark
Rigshospitalet, Denmark
Curasight

Completed

Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography (uPAR-PET)

Breast Cancer | Prostate Cancer | Urinary Bladder Cancer

Denmark
Rigshospitalet, Denmark

Terminated

uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Bone Metastases | Prostate Cancer Metastatic

Denmark
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction (GRGDMI)

Coronary Artery Disease

China
Peking Union Medical College Hospital
Beijing Tiantan Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma (GRGDG)

Glioma

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients (GRGDLC)

Lung Cancer

China
Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Recruiting

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Neuroendocrine Neoplasms

Japan
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

Metastasis | Tumor | Positron-Emission Tomography

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis (GRGDRA)

Rheumatoid Arthritis

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke (GRGDS)

Stroke

China
Peking Union Medical College Hospital

Unknown

68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis

Pulmonary Fibrosis, Unspecified

China
Peking Union Medical College Hospital

Unknown

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Lymphatic Disorders

China
The First Affiliated Hospital of Soochow University

Not yet recruiting

PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells

Lymphoma
Peking Union Medical College Hospital

Recruiting

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Neuroendocrine Tumors

China
SmartNuclide Biopharma
The First Affiliated Hospital of Soochow University

Recruiting

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Solid Tumor | Positron-Emission Tomography(PET)

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients

Breast Cancer

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients

Prostate Cancer

China
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases

Positron-Emission Tomography

China
Cytosite Biopharma Inc.
University of Alabama at Birmingham

Completed

Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.

Healthy Volunteers

United States
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

Lymphedema | Hemangioma | Arteriovenous Malformation | Neoplasms Lymph Nodes

China
Huashan Hospital

Recruiting

[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer

Non-small Cell Lung Cancer

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas

Glioma

China
Rigshospitalet, Denmark

Unknown

uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

Urinary Bladder Neoplasms

Denmark
Huashan Hospital

Recruiting

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Neoplasms | Positron-Emission Tomography

China
Huashan Hospital

Recruiting

A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
SmartNuclide Biopharma

Recruiting

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Solid Tumor | Positron-Emission Tomography(PET)

China
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Xijing Hospital

Unknown

68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients (GNNGB)

Glioma | Breast Cancer

China
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | Theranostic

China
Rigshospitalet, Denmark

Completed

Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

Breast Cancer | Prostate Cancer | Urinary Bladder Cancer

Denmark
YiHui Guan

Recruiting

Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer

Pancreatic Neoplasms | Positron Emission Tomography | Igestive System Neoplasms

China
Peking Union Medical College Hospital

Recruiting

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Lung Cancer | Neuroendocrine Neoplasm

China
Huashan Hospital

Recruiting

Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer

Colorectal Neoplasms | Positron-Emission Tomography

China
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Terminated

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Italy
Huashan Hospital

Recruiting

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Kidney Cancer | Positron Emission Tomography | Lymphomas

China
Karolinska University Hospital
Uppsala University; Stockholm South General Hospital

Recruiting

68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study

Cancer

Sweden
ABSCINT NV/SA

Not yet recruiting

HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011 (HERMIA)

Metastatic Breast Cancer

Belgium
Cytosite Biopharma Inc.
Massachusetts General Hospital; University of Alabama at Birmingham; Chang Gung...

Recruiting

Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

Lymphoma | Solid Tumor, Unspecified, Adult

United States, Taiwan
Peking Union Medical College Hospital

Unknown

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Tumor-Induced Osteomalacia

China
The First Affiliated Hospital of Xiamen University

Recruiting

PET Imaging of LAG-3 Expression

Tumor, Solid

China
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
Andrei Iagaru

No longer available

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Carcinoid Tumors | Islet Cell (Pancreatic NET) | Other Neuroendocrine Tumors

United States
University of California, Davis
United States Department of Defense

Recruiting

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Metastatic Nonsmall Cell Lung Cancer

United States
Nanjing First Hospital, Nanjing Medical University

Completed

Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

China

Search clinical trials for: 68Ga-NOTA-AE105

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations